RT Journal Article
SR Electronic
T1 Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.04.20053579
DO 10.1101/2020.04.04.20053579
A1 Omer Karin
A1 Yinon M. Bar-On
A1 Tomer Milo
A1 Itay Katzir
A1 Avi Mayo
A1 Yael Korem
A1 Boaz Dudovich
A1 Amos J. Zehavi
A1 Nadav Davidovich
A1 Ron Milo
A1 Uri Alon
YR 2020
UL http://medrxiv.org/content/early/2020/04/07/2020.04.04.20053579.abstract
AB Many countries have applied lockdown to suppress COVID-19, with devastating economic consequences. Here we propose exit strategies from lockdown that suppress the epidemic and provide sustainable, albeit reduced, economic activity. We use mathematical models to show that a cyclic schedule of 4-day work and 10-day lockdown, or similar variants that can be adapted in response to epidemiological observations, can in certain conditions suppress the epidemic while providing part-time employment. The cycle reduces the reproduction number R by a combination of reduced exposure time and a resonance effect where those infected during work days reach peak infectiousness during lockdown days. Throughout, full epidemiological measures need to continue including hygiene, physical distancing and extensive testing and contact tracing. Adaptive work-lockdown cycles can provide epidemic control and offer predictability to many economic sectors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data supplied in the submitted file